Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 904

1.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2006 Feb;27(1):1-10.

PMID:
16511362
2.

Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ.

J Dev Behav Pediatr. 2014 Sep;35(7):448-57. doi: 10.1097/DBP.0000000000000099.

PMID:
25180895
3.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
4.

Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.

Schertz M, Adesman AR, Alfieri NE, Bienkowski RS.

Pediatrics. 1996 Oct;98(4 Pt 1):763-9.

PMID:
8885958
5.

Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.

Varley CK, Vincent J, Varley P, Calderon R.

Compr Psychiatry. 2001 May-Jun;42(3):228-33.

PMID:
11349243
6.
7.
8.
9.

Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.

Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.

Aust N Z J Public Health. 2007 Apr;31(2):120-6.

PMID:
17461001
10.

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder.

Jensen P.

J Atten Disord. 2002;6 Suppl 1:S45-56. Review.

PMID:
12685518
11.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur. Epub 2009 Dec 29.

PMID:
20051220
13.

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

Stevenson RD, Wolraich ML.

Pediatr Clin North Am. 1989 Oct;36(5):1183-97. Review.

PMID:
2677938
14.

[Prescribing ritalin in combined modality management of hyperactivity with attention deficit].

Bricard C, Boidein F.

Encephale. 2001 Sep-Oct;27(5):435-43. French.

PMID:
11760693
16.

Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.

Levin H, Hanten G, Max J, Li X, Swank P, Ewing-Cobbs L, Dennis M, Menefee DS, Schachar R.

J Dev Behav Pediatr. 2007 Apr;28(2):108-18.

PMID:
17435461
17.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
18.
19.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

20.

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 May;44(5):418-27.

PMID:
15843763

Supplemental Content

Support Center